Raymond James Upgrades Texas Capital Bancshares to Strong Buy, Announces $70 Price Target
Raymond James analyst Michael Rose upgrades Texas Capital Bancshares (NASDAQ:TCBI) from Outperform to Strong Buy and announces $70 price target.
Raymond James Upgrades First Mid Bancshares to Outperform, Announces $45 Price Target
Raymond James analyst Daniel Tamayo upgrades First Mid Bancshares (NASDAQ:FMBH) from Market Perform to Outperform and announces $45 price target.
Raymond James Upgrades Pinnacle Finl Partners to Outperform, Announces $85 Price Target
Raymond James analyst Michael Rose upgrades Pinnacle Finl Partners (NASDAQ:PNFP) from Market Perform to Outperform and announces $85 price target.
Janney Montgomery Scott Upgrades EPR Props to Buy
Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.
BTIG Upgrades 1Life Healthcare to Buy, Announces $15 Price Target
BTIG analyst David Larsen upgrades 1Life Healthcare (NASDAQ:ONEM) from Neutral to Buy and announces $15 price target.
Wells Fargo Upgrades Bank of N.T Butterfield to Overweight
Wells Fargo analyst Timur Braziler upgrades Bank of N.T Butterfield (NYSE:NTB) from Equal-Weight to Overweight.
Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $102
Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.
RBC Capital Upgrades Cerence to Sector Perform, Lowers Price Target to $27
RBC Capital analyst Joseph Spak upgrades Cerence (NASDAQ:CRNC) from Underperform to Sector Perform and lowers the price target from $28 to $27.
Jefferies Upgrades Tenaris to Buy, Raises Price Target to $46
Jefferies analyst Alan Spence upgrades Tenaris (NYSE:TS) from Hold to Buy and raises the price target from $35.7 to $46.